About Early-onset spastic ataxia-myoclonic epilepsy-neuropathy syndrome
Early-onset spastic ataxia-myoclonic epilepsy-neuropathy syndrome is a rare disease catalogued by Orphanet (ORPHA:313772). It is associated with the AFG3L2 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Early-onset spastic ataxia-myoclonic epilepsy-neuropathy syndrome trials.
Search ClinicalTrials.gov for "Early-onset spastic ataxia-myoclonic epilepsy-neuropathy syndrome" or filter by Orphanet code ORPHA:313772 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Early-onset spastic ataxia-myoclonic epilepsy-neuropathy syndrome trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Early-onset spastic ataxia-myoclonic epilepsy-neuropathy syndrome. Updated daily.